Chakrabarti, Amit <br/><br/>
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.  [electronic resource] 

 -  Drug and alcohol dependence  Mar 2010 
 - 253-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1879-0046 
<br/><br/><label>Standard No.: </label>10.1016/j.drugalcdep.2009.10.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Buprenorphine--administration & dosage<br/>Data Interpretation, Statistical<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Naloxone--administration & dosage<br/>Narcotic Antagonists--therapeutic use<br/>Narcotics--therapeutic use<br/>National Institute on Drug Abuse (U.S.)<br/>Opioid-Related Disorders--drug therapy<br/>Outpatients<br/>Pain--chemically induced<br/>Pain Measurement<br/>Socioeconomic Factors<br/>Substance Withdrawal Syndrome--prevention & control<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Young Adult